Louisiana 2023 2023 Regular Session

Louisiana House Bill HB645 Comm Sub / Analysis

                    RÉSUMÉ DIGEST
ACT 183 (HB 645) 2023 Regular Session Dustin Miller
New law provides that it is unlawful for any person to knowingly or intentionally produce,
manufacture, distribute, or possess with intent to produce, manufacture, or distribute
Xylazine.
New law provides that whoever violates new law shall be imprisoned, with or without hard
labor, for not less than one year nor more than 10 years and, in addition, may be required to
pay a fine of not more than $15,000.
New law provides that it is unlawful for any person to knowingly or intentionally possess
Xylazine.
New law provides that whoever violates new law shall be imprisoned for not more than six
months and, in addition, may be required to pay a fine of not more than $500.
Provides that the new law crime of unlawful production, manufacturing, distribution, or
possession of Xylazine shall not apply to the following:
(1)The production, manufacturing, distribution, or possession of Xylazine in the course
of a legitimate veterinary practice.
(2)The production, manufacturing, distribution, or possession of a Xylazine bulk
chemical for pharmaceutical compounding by a licensed pharmacist or veterinarian.
(3)The possession of Xylazine pursuant to a valid prescription from a licensed
veterinarian.
New law defines "Xylazine" as Xylazine and any salt, sulfate, isomer, homologue, analogue,
or other preparation of Xylazine, and any salt, isomer, compound, derivative, precursor,
homologue, analogue, or other preparation thereof that is substantially chemically equivalent
or identical to Xylazine.
Effective August 1, 2023.
(Adds R.S. 40:989.4)